Advertisement
YOU ARE HERE: LAT HomeCollectionsRimonabant Drug
IN THE NEWS

Rimonabant Drug

FEATURED ARTICLES
HEALTH
February 20, 2006 | From Times wire reports
An anti-obesity drug that turns off the same brain circuits that trigger the marijuana-induced munchies appears to produce sustained weight loss among patients who took it in a two-year study. The report, in the Feb. 15 issue of the Journal of the American Medical Assn., also said the drug -- Sanofi-Aventis' Acomplia, or rimonabant -- needed more study for its long-term effects and said the research was limited by a high dropout rate.
ARTICLES BY DATE
HEALTH
February 20, 2006 | From Times wire reports
An anti-obesity drug that turns off the same brain circuits that trigger the marijuana-induced munchies appears to produce sustained weight loss among patients who took it in a two-year study. The report, in the Feb. 15 issue of the Journal of the American Medical Assn., also said the drug -- Sanofi-Aventis' Acomplia, or rimonabant -- needed more study for its long-term effects and said the research was limited by a high dropout rate.
Los Angeles Times Articles
|